the aid library

LIST OPTIONS

Filter

3425

What is Christian Ethics?

Langerak, E. (2020) C2

Christian morality consists of living one’s life with guidance and inspiration from the Christian scriptures and traditions. Christian ethics as an academic discipline uses these scriptures and traditions in developing and critiquing ethical norms and theories and applying them to ethical issues.... more

External Link

Geographical, landscape and host associations of Trypanosoma cruzi DTUs and lineages

Izeta-Alberdi, A.; Ibarra-Cerdena, C.; Moo-llanes, D.; Ramsey,J. BMC Part of Springer Nature (2016) CC

Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio... more

Download (357)

View PDF (378)

Troubles anxieux chez l’enfant et l’adolescent - Nature, developpement, traitement et prevention

R. M. Rapee IACAPAP (2012) C2

Troubles anxieux Chapitre F.1 Edition en français Traduction : Jean-Philippe Raynaud Avec le soutien de la SFPEADA

Download (5695)

View PDF (2023)

Technical Guidelines for Integrated Disease Surveillance and Response in Sierra Leone

GOVERNMENT OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION (2008) C1

Download (414)

View PDF (608)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (329)

View PDF (409)

Addressing comorbidity between mental disorders and major noncommunicable diseases

World Health Organization WHO; Regional Office for Europe (2017) C_WHO

Reduced healthy life expectancy due to the high burden of both mental ill health and noncommunicable diseases (NCDs) is a major public health concern in the European Region. The links between mental disorders and major NCDs are well established. In clinical practice, however, mental disorders in pa... more

Download (459)

View PDF (672)

Journey of ART Programme in India. Story of a decade

National AIDSControl (NACO), Government of India; Ministry of Health and Family Welfare, et al. (2015) C1

Celebrating ten years of success 2004-2014

Download (207)

View PDF (233)

Prevention and control of noncommunicable diseases in Turkey - The case for investment

Kontsevaya A, Farrington J, Balcılar M, Ergüder T World Health Organization (2018) C_WHO

Noncommunicable diseases (NCDs) such as cancer, cardiovascular diseases, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Turkey. This report provides evidence through three analyses that NCDs reduce economic output, and di... more

Download (1173)

View PDF (3689)

Ready to Respond: Skills gaps for responding to humanitarian crises in urban settings in the WASH and shelter sectors
recommended

RedR UK (2014) C1

This paper has been commissioned by RedR to identify gaps in skills, technology, and knowledge in urban humanitarian response in order to inform RedR’s project Ready to Respond which is looking to address these gaps in two specific areas: Water supply, sanitation, and hygiene; Shelter res... more

Download (702)

View PDF (1593)

Diagnostic errors. Technical Series on Safer Primary Care

World Health Organization WHO (2016) C_WHO

Download (270)

View PDF (447)

Planning Guidance for Response to a Nuclear Detonation

Interagency Policy Coordination Subcommitee for Preparedness & Response to Radiological and Nuclear Threats (2010)

The purpose of this guidance is to provide emergency planners with nuclear detonationspecific response recommendations to maximize the preservation of life in the event of an urban nuclear detonation. This guidance addresses the unique effects and impacts of a nuclear detonation such as scale of ... more

Download (212)

View PDF (345)

Medical device donations: considerations for solicitation and provision. Second edition

World Health Organization WHO (2024) CC

Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medical device donation in 2011, which has been now reviewed, with new evidence, new references on considerations for medical device solicitation and provisi... more

Download (1315)

View PDF (2679)

Global Atlas On Cardiovascular Disease Prevention And Control

World Health Organization, World Heart Federation, World Stroke Organization (2011) C_WHO

Download (196)

View PDF (401)

Prevalence and factors associated with prediabetes and diabetes mellitus in Kenya: results from a national survey

Mohamed, S.F.; Mwangi M., Mutua1 M.K., et al. BMC Public Health (2018) C1

Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215 https://doi.org/10.1186/s12889-018-6053-xpre-

External Link

2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Powers, W.J.; et al. (2018) C2

A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association AHA/ASA Guideline DOI: 10.1161/STR.0000000000000158

Download (188)

View PDF (230)

Prevention and control of noncommunicable diseases in Kazakhstan. The case for investment

World Health Organization WHO (2019) C_WHO

Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ... more

Download (235)

View PDF (372)

Les troubles du comportement alimentaire

J. Morris IACAPAP (2012) C2

Autres troubles Chapitre H.1 Edition en français Traduction : Priscille Gérardin et Malaïka Lasfar Sous la direction de : Priscille Gérardin Avec le soutien de la SFPEADA

Download (371)

View PDF (449)

Critical issue module 3 - Children with disabilities

ARC (2009) C1

ARC resource pack - Study material

Download (352)

View PDF (565)

Eating disorders: recognition and treatment

National Institute for Health and Care Excellence (NICE) (2017) C2

NICE guideline Published: 23 May 2017

Download (376)

View PDF (418)

Survey Report on 2015 Floods: The Project on Establishment of End-to-End Early Warning System for Natural Disaster

The Republic of the Union of Myanmar, Ministry of Social Welfare, Relief and Resettlement (MSWRR), Relief and Resettlement Department (RRD), Japan International Cooperation Agency (JICA)) (2016) C1

Torrential rains and the onset of Cyclone Komen triggered severe and widespread floods and landslides in July and August 2015 across 12 out of 14 states and regions in Myanmar. An estimated 1.6 million individuals were recorded as having been temporarily displaced from their homes by the disaster, a... more

Ready to Respond: Skills gaps for responding to humanitarian crises in urban settings in the WASH and shelter sectors recommended

Ready to Respond: Skills gaps for responding to humanitarian crises in urban settings in the WASH and shelter sectors
recommended